NeuroMetrix, Inc. (NURO)
USD 4.47
(1.08%)
USD 4.47
(1.08%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 3.94 Million USD | -31.35% |
| 2022 | 5.75 Million USD | -2.89% |
| 2021 | 5.92 Million USD | 12.8% |
| 2020 | 5.24 Million USD | 133.77% |
| 2019 | 2.24 Million USD | -69.58% |
| 2018 | 7.38 Million USD | 7.67% |
| 2017 | 6.85 Million USD | 39.52% |
| 2016 | 4.91 Million USD | 46.74% |
| 2015 | 3.34 Million USD | 13.75% |
| 2014 | 2.94 Million USD | -4.55% |
| 2013 | 3.08 Million USD | -22.62% |
| 2012 | 3.98 Million USD | -29.75% |
| 2011 | 5.67 Million USD | -17.15% |
| 2010 | 6.84 Million USD | -63.18% |
| 2009 | 18.6 Million USD | -15.86% |
| 2008 | 22.1 Million USD | -32.1% |
| 2007 | 32.56 Million USD | -21.9% |
| 2006 | 41.69 Million USD | 63.88% |
| 2005 | 25.44 Million USD | 94.69% |
| 2004 | 13.06 Million USD | 102.24% |
| 2003 | 6.46 Million USD | 126.32% |
| 2002 | 2.85 Million USD | 39.94% |
| 2001 | 2.04 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 491.91 Thousand USD | -4.85% |
| 2024 Q3 | 311.95 Thousand USD | -36.58% |
| 2024 Q1 | 517.01 Thousand USD | -39.03% |
| 2023 Q1 | 1.19 Million USD | -2.58% |
| 2023 Q2 | 1.11 Million USD | -6.6% |
| 2023 Q3 | 781.78 Thousand USD | -30.15% |
| 2023 FY | 3.94 Million USD | -31.35% |
| 2023 Q4 | 847.97 Thousand USD | 8.47% |
| 2022 Q4 | 1.23 Million USD | -3.48% |
| 2022 FY | 5.75 Million USD | -2.89% |
| 2022 Q1 | 1.79 Million USD | 44.33% |
| 2022 Q2 | 1.45 Million USD | -19.03% |
| 2022 Q3 | 1.27 Million USD | -12.24% |
| 2021 Q3 | 1.44 Million USD | -12.73% |
| 2021 Q4 | 1.24 Million USD | -13.97% |
| 2021 Q1 | 1.57 Million USD | 18.36% |
| 2021 Q2 | 1.65 Million USD | 4.82% |
| 2021 FY | 5.92 Million USD | 12.8% |
| 2020 Q3 | 1.49 Million USD | 73.27% |
| 2020 Q4 | 1.33 Million USD | -10.97% |
| 2020 FY | 5.24 Million USD | 133.77% |
| 2020 Q2 | 864.89 Thousand USD | -44.27% |
| 2020 Q1 | 1.55 Million USD | 46.08% |
| 2019 Q2 | -789.1 Thousand USD | -198.8% |
| 2019 Q3 | 1.17 Million USD | 248.74% |
| 2019 Q4 | 1.06 Million USD | -9.49% |
| 2019 FY | 2.24 Million USD | -69.58% |
| 2019 Q1 | 798.7 Thousand USD | -54.32% |
| 2018 FY | 7.38 Million USD | 7.67% |
| 2018 Q4 | 1.74 Million USD | -5.27% |
| 2018 Q3 | 1.84 Million USD | 2.47% |
| 2018 Q2 | 1.8 Million USD | -9.38% |
| 2018 Q1 | 1.98 Million USD | -4.06% |
| 2017 Q3 | 1.5 Million USD | -9.87% |
| 2017 Q2 | 1.67 Million USD | 3.86% |
| 2017 Q1 | 1.6 Million USD | -4.77% |
| 2017 FY | 6.85 Million USD | 39.52% |
| 2017 Q4 | 2.07 Million USD | 37.61% |
| 2016 FY | 4.91 Million USD | 46.74% |
| 2016 Q2 | 1.07 Million USD | 35.61% |
| 2016 Q3 | 1.35 Million USD | 26.28% |
| 2016 Q4 | 1.68 Million USD | 24.42% |
| 2016 Q1 | 792.73 Thousand USD | -30.35% |
| 2015 Q2 | 629.95 Thousand USD | -2.44% |
| 2015 Q1 | 645.69 Thousand USD | -13.96% |
| 2015 Q4 | 1.13 Million USD | 21.7% |
| 2015 FY | 3.34 Million USD | 13.75% |
| 2015 Q3 | 935.24 Thousand USD | 48.46% |
| 2014 Q3 | 788.8 Thousand USD | 14.58% |
| 2014 Q4 | 750.47 Thousand USD | -4.86% |
| 2014 FY | 2.94 Million USD | -4.55% |
| 2014 Q1 | 716.45 Thousand USD | -16.43% |
| 2014 Q2 | 688.43 Thousand USD | -3.91% |
| 2013 Q2 | 659.31 Thousand USD | -20.72% |
| 2013 Q1 | 831.67 Thousand USD | -1.77% |
| 2013 Q4 | 857.32 Thousand USD | 16.45% |
| 2013 FY | 3.08 Million USD | -22.62% |
| 2013 Q3 | 736.24 Thousand USD | 11.67% |
| 2012 Q4 | 846.63 Thousand USD | -12.79% |
| 2012 Q1 | 946.59 Thousand USD | -18.37% |
| 2012 FY | 3.98 Million USD | -29.75% |
| 2012 Q2 | 1.22 Million USD | 29.14% |
| 2012 Q3 | 970.77 Thousand USD | -20.59% |
| 2011 FY | 5.67 Million USD | -17.15% |
| 2011 Q1 | 1.64 Million USD | 2420.47% |
| 2011 Q3 | 1.4 Million USD | -3.94% |
| 2011 Q4 | 1.15 Million USD | -17.42% |
| 2011 Q2 | 1.46 Million USD | -11.37% |
| 2010 FY | 6.84 Million USD | -63.18% |
| 2010 Q4 | 65.43 Thousand USD | -96.83% |
| 2010 Q3 | 2.06 Million USD | -15.55% |
| 2010 Q2 | 2.44 Million USD | 2.88% |
| 2010 Q1 | 2.37 Million USD | -45.83% |
| 2009 Q3 | 4.49 Million USD | -6.76% |
| 2009 FY | 18.6 Million USD | -15.86% |
| 2009 Q4 | 4.39 Million USD | -2.4% |
| 2009 Q1 | 4.88 Million USD | 8.94% |
| 2009 Q2 | 4.82 Million USD | -1.22% |
| 2008 Q2 | 6 Million USD | -9.08% |
| 2008 Q1 | 6.6 Million USD | -8.91% |
| 2008 FY | 22.1 Million USD | -32.1% |
| 2008 Q3 | 5.02 Million USD | -16.35% |
| 2008 Q4 | 4.48 Million USD | -10.68% |
| 2007 Q3 | 8.24 Million USD | -1.97% |
| 2007 Q2 | 8.4 Million USD | -2.95% |
| 2007 Q4 | 7.24 Million USD | -12.07% |
| 2007 FY | 32.56 Million USD | -21.9% |
| 2007 Q1 | 8.66 Million USD | -18.51% |
| 2006 FY | 41.69 Million USD | 63.88% |
| 2006 Q1 | 8.94 Million USD | 16.16% |
| 2006 Q2 | 10.59 Million USD | 18.44% |
| 2006 Q4 | 10.63 Million USD | -7.76% |
| 2006 Q3 | 11.52 Million USD | 8.81% |
| 2005 Q2 | 5.97 Million USD | 20.22% |
| 2005 FY | 25.44 Million USD | 94.69% |
| 2005 Q4 | 7.69 Million USD | 13.36% |
| 2005 Q3 | 6.79 Million USD | 13.62% |
| 2005 Q1 | 4.97 Million USD | 18.13% |
| 2004 FY | 13.06 Million USD | 102.24% |
| 2004 Q4 | 4.2 Million USD | 19.27% |
| 2004 Q1 | 2.2 Million USD | 8.11% |
| 2004 Q2 | 3.12 Million USD | 41.88% |
| 2004 Q3 | 3.52 Million USD | 12.91% |
| 2003 Q2 | 1.45 Million USD | 26.81% |
| 2003 FY | 6.46 Million USD | 126.32% |
| 2003 Q4 | 2.03 Million USD | 11.5% |
| 2003 Q1 | 1.14 Million USD | 0.0% |
| 2003 Q3 | 1.82 Million USD | 25.94% |
| 2002 FY | 2.85 Million USD | 39.94% |
| 2001 FY | 2.04 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 2.55 Million USD | -54.801% |
| BrainsWay Ltd. | 23.09 Million USD | 82.905% |
| Cerus Corporation | 86.4 Million USD | 95.431% |
| Envoy Medical, Inc. | -473 Thousand USD | 934.548% |
| electroCore, Inc. | 13.22 Million USD | 70.154% |
| Helius Medical Technologies, Inc. | 61 Thousand USD | -6371.169% |
| IceCure Medical Ltd | 1.3 Million USD | -203.647% |
| Inogen, Inc. | 126.69 Million USD | 96.884% |
| OrthoPediatrics Corp. | 111.25 Million USD | 96.452% |
| Lucid Diagnostics Inc. | -6.05 Million USD | 165.246% |
| Monogram Orthopaedics, Inc. | -47.33 Thousand USD | 8439.135% |
| MaxCyte, Inc. | 36.54 Million USD | 89.199% |
| NeuroOne Medical Technologies Corporation | 456.51 Thousand USD | -764.68% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | -4540.739% |
| Orthofix Medical Inc. | 486.27 Million USD | 99.188% |
| PAVmed Inc | -3.96 Million USD | 199.481% |
| Rapid Micro Biosystems, Inc. | -5.48 Million USD | 171.967% |
| RxSight, Inc. | 53.76 Million USD | 92.658% |
| Sight Sciences, Inc. | 69.17 Million USD | 94.294% |
| SI-BONE, Inc. | 109.42 Million USD | 96.392% |
| TELA Bio, Inc. | 40.11 Million USD | 90.159% |
| Treace Medical Concepts, Inc. | 151.93 Million USD | 97.402% |
| Vivos Therapeutics, Inc. | 8.27 Million USD | 52.274% |
| Acutus Medical, Inc. | -3.13 Million USD | 225.834% |
| Talis Biomedical Corporation | 371 Thousand USD | -963.993% |
| Spectral AI, Inc. | 7.88 Million USD | 49.906% |
| Nano-X Imaging Ltd. | -6.59 Million USD | 159.882% |
| CVRx, Inc. | 33.03 Million USD | 88.052% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 739.52 Thousand USD | -433.776% |
| Bioventus Inc. | 328.19 Million USD | 98.797% |
| Venus Concept Inc. | 52.16 Million USD | 92.433% |
| TriSalus Life Sciences, Inc. | 15.9 Million USD | 75.183% |
| LivaNova PLC | 771.25 Million USD | 99.488% |
| 908 Devices Inc. | 25.32 Million USD | 84.411% |
| Alphatec Holdings, Inc. | 310.2 Million USD | 98.727% |
| Nemaura Medical Inc. | -1.47 Million USD | 367.369% |
| NeuroPace, Inc. | 48.12 Million USD | 91.797% |
| LENSAR, Inc. | 21.1 Million USD | 81.298% |
| Apyx Medical Corporation | 14.12 Million USD | 72.048% |
| Cutera, Inc. | 41.49 Million USD | 90.487% |
| STRATA Skin Sciences, Inc. | 18.46 Million USD | 78.618% |
| BioSig Technologies, Inc. | 18 Thousand USD | -21830.072% |
| Anika Therapeutics, Inc. | 103.08 Million USD | 96.171% |
| ClearPoint Neuro, Inc. | 13.61 Million USD | 71.005% |
| Integra LifeSciences Holdings Corporation | 888.39 Million USD | 99.556% |
| Axonics, Inc. | 274.55 Million USD | 98.562% |
| Outset Medical, Inc. | 29 Million USD | 86.388% |
| IRIDEX Corporation | 21.8 Million USD | 81.898% |
| PROCEPT BioRobotics Corporation | 71.04 Million USD | 94.444% |
| IRadimed Corporation | 50.15 Million USD | 92.13% |
| Tivic Health Systems, Inc. | 287 Thousand USD | -1275.405% |
| INVO Bioscience, Inc. | 1.08 Million USD | -263.436% |
| Telesis Bio, Inc. | 16.95 Million USD | 76.711% |
| Viemed Healthcare, Inc. | 112.78 Million USD | 96.5% |
| Varex Imaging Corporation | 256.9 Million USD | 98.463% |
| Quipt Home Medical Corp. | 163.84 Million USD | 97.591% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 1072.269% |
| Pulmonx Corporation | 50.75 Million USD | 92.222% |
| Dynatronics Corporation | 7.63 Million USD | 48.298% |
| Modular Medical, Inc. | -768 Thousand USD | 613.986% |
| ReShape Lifesciences Inc. | 5.54 Million USD | 28.85% |
| Semler Scientific, Inc. | 61.2 Million USD | 93.55% |
| InMode Ltd. | 411.34 Million USD | 99.04% |
| Bruker Corporation | 1.51 Billion USD | 99.74% |
| Cytosorbents Corporation | 22.39 Million USD | 82.371% |
| DexCom, Inc. | 2.28 Billion USD | 99.828% |
| Align Technology, Inc. | 2.71 Billion USD | 99.855% |
| Viveve Medical, Inc. | 620 Thousand USD | -536.68% |
| ZimVie Inc. | 290.38 Million USD | 98.641% |
| Movano Inc. | -158 Thousand USD | 2598.363% |
| Cytek Biosciences, Inc. | 109.42 Million USD | 96.393% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | -4540.739% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 367.69 Million USD | 98.926% |
| Profound Medical Corp. | 4.51 Million USD | 12.552% |
| Insulet Corporation | 1.15 Billion USD | 99.66% |
| enVVeno Medical Corporation | -546 Thousand USD | 822.969% |
| Surmodics, Inc. | 93.05 Million USD | 95.758% |
| iCAD, Inc. | 14.53 Million USD | 72.844% |
| Nuwellis, Inc. | 4.98 Million USD | 20.782% |
| Biotricity, Inc. | 8.35 Million USD | 52.761% |
| iRhythm Technologies, Inc. | 331.8 Million USD | 98.81% |
| Aethlon Medical, Inc. | -359.05 Thousand USD | 1199.383% |
| InspireMD, Inc. | 1.8 Million USD | -118.451% |
| PAVmed Inc. | -3.96 Million USD | 199.481% |
| BIOLASE, Inc. | 16.72 Million USD | 76.397% |
| Beyond Air, Inc. | -1.3 Million USD | 402.021% |
| FONAR Corporation | 45.14 Million USD | 91.255% |
| AxoGen, Inc. | 127.87 Million USD | 96.913% |
| Vivani Medical, Inc. | -357 Thousand USD | 1205.718% |
| Tactile Systems Technology, Inc. | 195.13 Million USD | 97.977% |
| Inari Medical, Inc. | 434.56 Million USD | 99.092% |
| UFP Technologies, Inc. | 112.22 Million USD | 96.483% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 12.51 Thousand USD | -31431.376% |
| Tenon Medical, Inc. | 1.24 Million USD | -218.083% |
| Autonomix Medical, Inc. Common Stock | -81 Thousand USD | 4973.349% |
| Co-Diagnostics, Inc. | 2.62 Million USD | -50.258% |
| AdaptHealth Corp. | 479.56 Million USD | 99.177% |
| Sintx Technologies, Inc. | 1.84 Million USD | -114.184% |
| NanoVibronix, Inc. | 1.53 Million USD | -156.826% |
| Quanterix Corporation | 70.64 Million USD | 94.412% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 1072.269% |
| Sensus Healthcare, Inc. | 14.06 Million USD | 71.925% |
| Pacific Biosciences of California, Inc. | 52.78 Million USD | 92.521% |
| TransMedics Group, Inc. | 154.09 Million USD | 97.438% |
| ReWalk Robotics Ltd. | 4.45 Million USD | 11.354% |
| Hyperfine, Inc. | 4.75 Million USD | 17.019% |
| Establishment Labs Holdings Inc. | 106.97 Million USD | 96.31% |
| Biomerica, Inc. | 611 Thousand USD | -546.058% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 41.68 Million USD | 90.531% |
| Bluejay Diagnostics, Inc. | -780.95 Thousand USD | 605.46% |
| Silk Road Medical, Inc | 127.08 Million USD | 96.894% |